CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

LUPIN LTD.

NSE : LUPINBSE : 500257ISIN CODE : INE326A01037Industry : Pharmaceuticals & DrugsHouse : Lupin
BSE2410.0040.55 (+1.71 %)
PREV CLOSE () 2369.45
OPEN PRICE () 2374.30
BID PRICE (QTY) 2409.55 (2)
OFFER PRICE (QTY) 2411.00 (14)
VOLUME 9213
TODAY'S LOW / HIGH ()2371.00 2431.85
52 WK LOW / HIGH ()1838.65 2530
NSE2411.3040.8 (+1.72 %)
PREV CLOSE() 2370.50
OPEN PRICE () 2371.00
BID PRICE (QTY) 2411.30 (54)
OFFER PRICE (QTY) 2412.10 (15)
VOLUME 661883
TODAY'S LOW / HIGH() 2368.10 2432.10
52 WK LOW / HIGH ()1836.8 2529.5
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 1983

Management Info :

Manju D Gupta - Chairman Nilesh Gupta - Managing Director

Registered Office :

Address : Kalpataru Inspire, 3rd Floor,Off. Western Express Highway,Santacruz (East),
Mumbai,
Maharashtra-400055

Phone : 022 66402323

Email : info@lupin.com

Website : www.lupin.com

Registrar's Details : MUFG Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE
NEWS
22Jul Pharma stocks trade lower as Trump pro
Pharmaceutical stocks were trading under pressure on the BSE after US Pr..
21Jul Lupin informs about acquisition
Pursuant to Regulation 30 read with Schedule III of the SEBI Listing Reg..
14Jul Lupin informs about press release
Lupin has informed that it enclosed a Press Release titled ‘Lupin Recogn..
02Jul Lupin gets EIR from USFDA for Somerset
Lupin has received the Establishment Inspection Report (EIR) from the Un..
29Jun Lupin moves up on getting USFDA’s tent
Lupin is currently trading at Rs. 2362.80, up by 20.65 points or 0.88% f..
Financials
in Millions
QTR Mar 26 ANNUAL 26
Net Profit21636.963665.6
Gross Profit 26023.5 76942.5
Operating Profit 23704.481163.3
Net Sales 52346195126.6
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Neuland Laboratories (BSE)
 19100.00 (2.85%)
M.Cap ( in Cr)
24503.23
Divi's Laboratories (BSE)
 7419.95 (2.39%)
M.Cap ( in Cr)
196203.85
Caplin Point Labs. (BSE)
 2618.50 (6.24%)
M.Cap ( in Cr)
19953.07
Hester Biosciences (BSE)
 2500.25 (5.74%)
M.Cap ( in Cr)
2096.01
Bharat Parenterals (BSE)
 1548.80 (7.83%)
M.Cap ( in Cr)
1067.43
Shareholding Pattern
PROMOTERS 46.85%
MUTUAL FUNDS/UTI 14.84%
FI/BANKS/INSURANCE 6.98%
NON-INSTITUTION 6.08%
GOVERNMENT 0%
FII 0%

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalpataru Multiplier Ltd.
Designed ,Developed & Content Powered by  Accord Fintech Pvt. Ltd.
SENSEX76734.68674.91 (0.89%)
NIFTY23962.70195.25 (0.82%)
Dow Jones 51947.25235.60 (0.46%)
Nasdaq 24975.82-161.87 (-0.64%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI